97 related articles for article (PubMed ID: 23207411)
61. Novel conformationally extended naphthalene-based inhibitors of farnesyltransferase.
Burns CJ; Guitton JD; Baudoin B; Lelièvre Y; Duchesne M; Parker F; Fromage N; Commerçon A
J Med Chem; 1997 Jun; 40(12):1763-7. PubMed ID: 9191950
[No Abstract] [Full Text] [Related]
62. Structural feature study of benzofuran derivatives as farnesyltransferase inhibitors.
Moorthy NS; Sousa SF; Ramos MJ; Fernandes PA
J Enzyme Inhib Med Chem; 2011 Dec; 26(6):777-91. PubMed ID: 21381884
[TBL] [Abstract][Full Text] [Related]
63. Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches.
González MP; Caballero J; Tundidor-Camba A; Helguera AM; Fernández M
Bioorg Med Chem; 2006 Jan; 14(1):200-13. PubMed ID: 16185882
[TBL] [Abstract][Full Text] [Related]
64. In vitro and in vivo evaluation of two rational-designed nonpeptidic farnesyltransferase inhibitors on HT29 human colon cancer cell lines.
Wlodarczyk N; Gilleron P; Millet R; Houssin R; Goossens JF; Lemoine A; Pommery N; Wei MX; Hénichart JP
Oncol Res; 2005; 16(3):107-18. PubMed ID: 16925112
[TBL] [Abstract][Full Text] [Related]
65. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I.
Li Q; Fang H; Wang X; Hu L; Xu W
Eur J Med Chem; 2009 Dec; 44(12):4819-25. PubMed ID: 19683842
[TBL] [Abstract][Full Text] [Related]
66. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
[TBL] [Abstract][Full Text] [Related]
67. Discovery of novel tricyclic compounds as squalene synthase inhibitors.
Ichikawa M; Ohtsuka M; Ohki H; Haginoya N; Itoh M; Sugita K; Usui H; Suzuki M; Terayama K; Kanda A
Bioorg Med Chem; 2012 May; 20(9):3072-93. PubMed ID: 22464687
[TBL] [Abstract][Full Text] [Related]
68. Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors.
Suzuki N; Suzuki T; Ota Y; Nakano T; Kurihara M; Okuda H; Yamori T; Tsumoto H; Nakagawa H; Miyata N
J Med Chem; 2009 May; 52(9):2909-22. PubMed ID: 19419205
[TBL] [Abstract][Full Text] [Related]
69. Synthesis and biological evaluation of potential bisubstrate inhibitors of protein farnesyltransferase. Design and synthesis of functionalized imidazoles.
de Figueiredo RM; Coudray L; Dubois J
Org Biomol Chem; 2007 Oct; 5(20):3299-309. PubMed ID: 17912382
[TBL] [Abstract][Full Text] [Related]
70. 3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective lead.
Soth M; Abbot S; Abubakari A; Arora N; Arzeno H; Billedeau R; Dewdney N; Durkin K; Frauchiger S; Ghate M; Goldstein DM; Hill RJ; Kuglstatter A; Li F; Loe B; McCaleb K; McIntosh J; Papp E; Park J; Stahl M; Sung ML; Suttman R; Swinney DC; Weller P; Wong B; Zecic H; Gabriel T
